SCHEMBL7305924

SCHEMBL7305924

COc1ccc(SC2CCCCC2C(=O)NOC(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.43
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MDM2 Q00987 1/20 0.40
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
EPHX2 P34913 3/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
EPHX1 P07099 1/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP13 P45452 1/20 0.37
MTNR1A P48039 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310798 0.98 MMP2 (0.41) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7310802 0.98 MMP2 (0.41) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7308764 0.80 SMN1; SMN2 (0.47) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL31630289 0.79 MMP2 (0.43) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7311871 0.78 SMN1; SMN2 (0.44) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7311882 0.78 SMN1; SMN2 (0.44) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL7311878 0.78 SMN1; SMN2 (0.44) CTSKRAB9ANPC1ALDH1A1SMN1; SMN2
Anisole SCHEMBL7305932 0.76 FNTA (0.41) RAB9ANPC1ALDH1A1SMN1; SMN2MDM2
SCHEMBL7305247 0.75 MMP9 (0.70) SMN1; SMN2MMP2MMP9EPHX2MMP1
Anisole SCHEMBL7310806 0.73 SCN9A (0.42) RAB9ANPC1ALDH1A1SMN1; SMN2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed